In a quantitative real-time PCR (qPCR) assay, cinnamomulactone was found to effectively reduce the gene expressions of MMP-1 and MMP-3 in TNF-stimulated synovial fibroblasts, suggesting a potential therapeutic effect on RA (98). The gene discussed is MMP1; the disease is rheumatoid arthritis.